Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash and Cash Equivalents, at Carrying Value	$ 22,494	$ 23,350
Accounts receivable, net of allowance for doubtful accounts of $4,136 and $3,397 at 2015 and 2014, respectively	145,689	197,163
Inventories, net	40,906	43,371
Prepaid Expense, Current	12,053	14,246
Income Taxes Receivable, Current	7,209	10,980
Other Assets, Current	10,196	12,710
TOTAL CURRENT ASSETS	238,547	301,820
Property, Plant and Equipment, Net	143,211	149,014
INTANGIBLES, net	10,041	10,642
GOODWILL	178,159	164,464
Deferred Tax Assets, Net, Noncurrent	11,693	3,876
Other Assets, Noncurrent	43,607	43,509
TOTAL ASSETS	625,258	673,325
CURRENT LIABILITIES:
Accounts payable	33,474	47,084
Accrued payroll and related costs	36,475	34,617
Taxes other than payroll and income	9,495	11,199
Unearned revenues	14,101	11,009
Income taxes payable	1,733	8,333
Other accrued expenses	25,480	19,624
TOTAL CURRENT LIABILITIES	120,758	131,866
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	430,987	353,672
DEFERRED COMPENSATION	43,478	42,705
Deferred Tax Liabilities, Noncurrent	4,881	7,210
Other Liabilities, Noncurrent	$ 48,853	$ 43,879
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	$ 0	$ 0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 44,350,002 issued and 42,375,905 outstanding at 2015 and 45,600,002 issued and 43,636,984 outstanding at 2014	1,142	1,174
Additional paid-in capital	0	0
Retained Earnings (Accumulated Deficit)	219,207	415,906
Accumulated Other Comprehensive Income (Loss), Net of Tax	(10,538)	(11,894)
Treasury shares (at cost), 1,974,097 at 2015 and 1,963,018 at 2014	(238,875)	(317,613)
Total Core Laboratories N.V. shareholders' equity	(29,064)	87,573
Stockholders' Equity Attributable to Noncontrolling Interest	5,365	6,420
TOTAL EQUITY	(23,699)	93,993
TOTAL LIABILITIES AND EQUITY	$ 625,258	$ 673,325